Immune Effector Cells

The main objective of FACT’s Immune Effector Cell (IEC) Standards is to promote quality practice in immune effector cell administration. FACT also administers an associated voluntary, peer-led accreditation program that promotes patient safety, protects the research environment, and assists health care entities with achieving controlled processes, receiving grant funding, and gaining institutional support. FACT is committed to supporting efforts to make quality immune effector cellular therapy accessible to patients much like it did for blood and marrow transplantation and cord blood banking. Several resources are available to assist with understanding immune effector cells and implementing FACT Standards.

Notable Publications



FACT Consulting

Accreditation Success Story

The Héma-Québec Public Cord Blood Bank (CBB) was created in 2004 to meet the needs of Quebecers and to contribute to the international effort towards a high-quality global inventory of cord blood units. Read more